Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
COVID-19에 대한 회복기 혈장 요법의 인터페론-α2 자가항체
Original Article
Published on
Journal: Journal of Clinical Immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료제,
Journal: Journal of Clinical Immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료제,
[키워드] age
Analysis
association
Auto-antibodies
auto-antibody
Concentration
condition
convalescent plasma
convalescent plasma treatment
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
critically ill COVID-19 patients
determine
disease severity
Donor
Effect
ELISA
healthy controls
Human plasma
ICU patient
ICU Patients
IFN-α2
interferon
Interferon alpha
longitudinal
Longitudinal analyses
Neutralization assay
neutralized
Neutralizing
not neutralize
Patient
performed
physiological
plasma
positive
proportion
proportions
respiratory
Respiratory illness
respiratory illnesses
respiratory tract
Result
risk
SARS-CoV-2
sera
serum
Sex
supplementary material
survival
tested
transfer
Viral
viral clearance
Viral load
virological outcome
[DOI] 10.1007/s10875-021-01168-3 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1007/s10875-021-01168-3 PMC 바로가기 [Article Type] Original Article